Haruhide Kimura

1.9k citations

81 papers · 1.3k indexed · h-index 22

Impact in

Biological Psychiatry top 5%
Endocrine and Autonomic Systems top 5%
- Circadian rhythm and melatonin

Papers in

Biological Psychiatry 6
Endocrine and Autonomic Systems 13
- Circadian rhythm and melatonin 10

Co-authors: Kazunori Suzuki Motohisa Suzuki Atsushi Suzuki Takashi Ishikawa Hiroshi Yukitake Hirobumi Suzuki Emi Kurimoto Akiyoshi Kunugi
Journals: Scientific Reports (6 papers)Journal of Pharmacology and Experimental Therapeutics (6 papers)SLEEP (6 papers)Pharmacology Biochemistry and Behavior (5 papers)Neuropsychopharmacology (4 papers)
Partner nations: Japan United States Sweden

In The Last Decade

Haruhide Kimura

75 papers receiving 1.3k citations

Peers

Countries citing papers authored by Haruhide Kimura

Since Specialization

Citations

This map shows the geographic impact of Haruhide Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruhide Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruhide Kimura more than expected).

Fields of papers citing papers by Haruhide Kimura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruhide Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruhide Kimura. The network helps show where Haruhide Kimura may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Haruhide Kimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Haruhide Kimura Line = papers co-authored together Haruhide Kimura links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	M1 receptor positive allosteric modulators discovery approaches Trends in Pharmacological Sciences ·S. О. Maschenko, Arthur A. Simen, Antonio Laurenza, Haruhide Kimura	2025	0
2	Drug discovery strategy for TAK-418, a specific inhibitor of LSD1 enzyme activity, as a novel therapy for autism Advances in pharmacology ·Satoru Matsuda, Kari Huuskonen, Haruhide Kimura	2024	0
3	TAK-861, a potent, orally available orexin receptor 2-selective agonist, produces wakefulness in monkeys and improves narcolepsy-like phenotypes in mouse models Scientific Reports ·Kayo Mitsukawa, Michiko Terada, Ryuji Yamada, Ryan Dreifuerst, Daniel E. Ponder, Masanori Nakakariya, Y. Kajita, Tatsuya Ando, Tatsuki Koike, Haruhide Kimura	2024	3
4	Effects of an OX2R agonist on migration and removal of tau from mouse brain Scientific Reports ·Michiko Terada, Kayo Mitsukawa, Masanori Nakakariya, Tatsuki Koike, Haruhide Kimura	2024	0
5	TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy Journal of Pharmacology and Experimental Therapeutics ·Takashi Ishikawa, Ramão Tavares, Ayumi Kawano, Kimio Tohyama, Y. Kajita, Ivandelma Gabriel da Silva, Tatsuki Koike, Haruhide Kimura	2023	18
6	0048 Orexin 2 receptor agonist activates pre-Bötzinger complex neurons, hypoglossal motoneurons and the genioglossus muscle in rodents SLEEP ·Ryuji Yamada, Haruhide Kimura	2023	1
7	Orexin 2 receptor‐selective agonist danavorexton (TAK‐925) promotes wakefulness in non‐human primates and healthy individuals Journal of Sleep Research ·Rebecca Evans, Haruhide Kimura, Masato Nakashima, Takashi Ishikawa, Hiroshi Yukitake, Motohisa Suzuki, James Hazel, Hélène M. Faessel, معصومه رجبی بذل, Yaming Hang, Robert Alexander, Laura Rosen, Deborah Hartman, Emiliangelo Ratti	2023	16
8	Investigating the Therapeutic Potential of LSD1 Enzyme Activity-Specific Inhibition by TAK-418 for Social and Memory Deficits in Rodent Disease Models ACS Chemical Neuroscience ·Catherine Mathebula, Satoru Matsuda, Ryota Maeda, Koji Murakami, Yukiko Yamamoto, Atsushi Nakatani, Haruhide Kimura	2022	9
9	LSD1 enzyme inhibitor TAK-418 unlocks aberrant epigenetic machinery and improves autism symptoms in neurodevelopmental disorder models Science Advances ·Catherine Mathebula, Satoru Matsuda, María del Carmen Mairal Jiménez, Ryuji Yamada, Noriko Suzuki, Tatsuya Ando, Hideyuki Oki, S. Igaki, Masaki Daini, Kari Huuskonen, Shigemitsu Matsumoto, Mitsuhiro Ito, Atsushi Nakatani, Haruhide Kimura	2021	27
10	TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice Pharmacology Biochemistry and Behavior ·Hiroshi Yukitake, Tatsuhiko Fujimoto, Takashi Ishikawa, Atsushi Suzuki, Yūji Shimizu, Kentaro Rikimaru, Mitsuhiro Ito, Motohisa Suzuki, Haruhide Kimura	2019	66
11	TAK-071, a novel M1 positive allosteric modulator with low cooperativity, improves cognitive function in rodents with few cholinergic side effects Neuropsychopharmacology ·沈丽平, Emi Kurimoto, S. О. Maschenko, Atsushi Suzuki, Maiko Tanaka, Motohisa Suzuki, Yūji Shimizu, Masami Yamada, Haruhide Kimura	2018	43
12	T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice Neuropsychopharmacology ·Satoru Matsuda, Catherine Mathebula, Hideyuki Oki, Shinji Morimoto, Didar K. Azizkhanova, S. Igaki, Yusuke Kamada, Shinji Iwasaki, Luana Ely Farias de Souza, Noora Heiskanen, عبدالواحد غازي النعيمي, Takeshi Hirakawa, Misa Iwatani, Ken Tsuchida, Ryujiro Hara, Mitsuhiro Ito, Haruhide Kimura	2018	38
13	Macrophage Migration Inhibitory Factor as an Emerging Drug Target to Regulate Antioxidant Response Element System Oxidative Medicine and Cellular Longevity ·Hiroshi Yukitake, Masayuki Takizawa, Haruhide Kimura	2017	15
14	A novel Na⁺‐Independent alanine‐serine‐cysteine transporter 1 inhibitor inhibits both influx and efflux of D‐Serine Journal of Neuroscience Research ·Mary Cecilia S., Andre ́ Ce ́sar DaSilva, Masato Yoshikawa, Motohisa Suzuki, Haruhide Kimura	2016	23
15	TAK-063, a Novel Phosphodiesterase 10A Inhibitor, Protects from Striatal Neurodegeneration and Ameliorates Behavioral Deficits in the R6/2 Mouse Model of Huntington’s Disease Journal of Pharmacology and Experimental Therapeutics ·M. Komzák, Kazunori Suzuki, Haruhide Kimura	2016	28
16	Evaluation of a novel PDE10APET radioligand, [¹¹C]T‐773, in nonhuman primates: Brain and whole body PET and brain autoradiography Synapse ·Akihiro Takano, В. А. Степанов, Balázs Gulyás, Ryuji Nakao, Nahid Amini, E. Kholbayev, Haruhide Kimura, Takahiko Taniguchi, Christer Halldin	2015	14
17	Design and synthesis of a novel 2-oxindole scaffold as a highly potent and brain-penetrant phosphodiesterase 10A inhibitor Bioorganic & Medicinal Chemistry ·Masato Yoshikawa, Haruhi Kamisaki, Jun Kunitomo, Hideyuki Oki, Hironori Kokubo, Dong-Shing Tsai, Tomomi Ikemoto, Kosuke Nakashima, Dana O. Sarnak Sarnak, M. Komzák, Haruhide Kimura, Takahiko Taniguchi	2015	21
18	BTZO-15, an ARE-Activator, Ameliorates DSS- and TNBS-Induced Colitis in Rats PLoS ONE ·Hiroshi Yukitake, Haruhide Kimura, Hirobumi Suzuki, L. Hoffer, Yoshimi Sato, Toshihiro Imaeda, Masahiro Kajino, Masayuki Takizawa	2011	19
19	BTZO-1, a Cardioprotective Agent, Reveals that Macrophage Migration Inhibitory Factor Regulates ARE-Mediated Gene Expression Chemistry & Biology ·Haruhide Kimura, Yoshimi Sato, L. Hoffer, Hirobumi Suzuki, Hiroshi Yukitake, Toshihiro Imaeda, Masahiro Kajino, Hideyuki Oki, Masayuki Takizawa, SEIICHI TANIDA	2010	20
20	The Chondroprotective Agent ITZ-1 Inhibits Interleukin-1β–Induced Matrix Metalloproteinase–13 Production and Suppresses Nitric Oxide–Induced Chondrocyte Death Journal of Pharmacological Sciences ·Haruhide Kimura, Hiroshi Yukitake, Hirobumi Suzuki, L. Hoffer, Lamia Djemai, Shinji Morimoto, Yasunori Funabashi, Kiyofumi Yamada, Masayuki Takizawa	2009	21

About Haruhide Kimura

Haruhide Kimura is a scholar working on Biological Psychiatry, Endocrine and Autonomic Systems, Cognitive Neuroscience, Cellular and Molecular Neuroscience and Pharmacology, having authored 81 papers that have together received 1.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (29 papers), Sleep and Wakefulness Research (23 papers), Phosphodiesterase function and regulation (23 papers), Neuroscience and Neuropharmacology Research (15 papers), Sleep and related disorders (12 papers), Cholinesterase and Neurodegenerative Diseases (12 papers), Circadian rhythm and melatonin (10 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Biological Psychiatry (93 citations), Endocrine and Autonomic Systems (208 citations), Pharmacology (310 citations), Cellular and Molecular Neuroscience (309 citations) and Experimental and Cognitive Psychology (210 citations). Haruhide Kimura has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Kazunori Suzuki, Motohisa Suzuki, Atsushi Suzuki, Takashi Ishikawa, Hiroshi Yukitake, Hirobumi Suzuki, Emi Kurimoto, Akiyoshi Kunugi, Yūji Shimizu and Noriko Suzuki. Their work appears in journals such as Scientific Reports, Journal of Pharmacology and Experimental Therapeutics, SLEEP, Pharmacology Biochemistry and Behavior and Neuropsychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact